Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra
Oct 15, 2020•over 4 years ago
Round Type
series b
Description
Leaps by Bayer, the impact investment arm of Bayer AG, today announced a USD 8 million financial investment in US-based clinical-stage medical dermatology biotech company Azitra Inc. The partnership will focus on developing cutting-edge skin products using engineered and wild-type bacteria for biotherapeutic, over-the-counter (OTC) and cosmetic applications leveraging Azitra’s technology platform for both live therapeutic products (LBPs) and consumer programs. Existing investors, Bios Partners and Connecticut Innovations also participated in the round.
FundzWatch™ Score
64
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood